Early Gray Matter Volume Loss in MAPT H1H1 de Novo PD Patients: A Possible Association With Cognitive Decline

The MAPT H1 haplotype has been identified as a predictor of cognitive decline in Parkinson's disease (PD). However, its underlying pathological mechanisms have not been fully established. In this work, using a cohort of 120 de novo PD patients with preserved cognition from the Parkinson's...

詳細記述

書誌詳細
出版年:Frontiers in Neurology
主要な著者: Frederic Sampedro, Juan Marín-Lahoz, Saul Martínez-Horta, Javier Pagonabarraga, Jaime Kulisevsky
フォーマット: 論文
言語:英語
出版事項: Frontiers Media S.A. 2018-05-01
主題:
オンライン・アクセス:https://www.frontiersin.org/article/10.3389/fneur.2018.00394/full
_version_ 1856997855743442944
author Frederic Sampedro
Frederic Sampedro
Frederic Sampedro
Juan Marín-Lahoz
Juan Marín-Lahoz
Juan Marín-Lahoz
Saul Martínez-Horta
Saul Martínez-Horta
Saul Martínez-Horta
Javier Pagonabarraga
Javier Pagonabarraga
Javier Pagonabarraga
Jaime Kulisevsky
Jaime Kulisevsky
Jaime Kulisevsky
author_facet Frederic Sampedro
Frederic Sampedro
Frederic Sampedro
Juan Marín-Lahoz
Juan Marín-Lahoz
Juan Marín-Lahoz
Saul Martínez-Horta
Saul Martínez-Horta
Saul Martínez-Horta
Javier Pagonabarraga
Javier Pagonabarraga
Javier Pagonabarraga
Jaime Kulisevsky
Jaime Kulisevsky
Jaime Kulisevsky
author_sort Frederic Sampedro
collection DOAJ
container_title Frontiers in Neurology
description The MAPT H1 haplotype has been identified as a predictor of cognitive decline in Parkinson's disease (PD). However, its underlying pathological mechanisms have not been fully established. In this work, using a cohort of 120 de novo PD patients with preserved cognition from the Parkinson's Progression Markers Initiative (PPMI) database, we found that patients who were homozygous for MAPT H1 had less gray matter volume (GMV) and greater 1-year GMV loss than patients without this genetic profile. Importantly, these changes were associated with a longitudinal worsening of cognitive indicators. Our findings suggest that early GMV loss in MAPT H1H1 PD patients increases their risk to develop cognitive decline.
format Article
id doaj-art-d8a9ea971f924f5ea97d36efbfdadb41
institution Directory of Open Access Journals
issn 1664-2295
language English
publishDate 2018-05-01
publisher Frontiers Media S.A.
record_format Article
spelling doaj-art-d8a9ea971f924f5ea97d36efbfdadb412025-08-19T19:51:04ZengFrontiers Media S.A.Frontiers in Neurology1664-22952018-05-01910.3389/fneur.2018.00394387084Early Gray Matter Volume Loss in MAPT H1H1 de Novo PD Patients: A Possible Association With Cognitive DeclineFrederic Sampedro0Frederic Sampedro1Frederic Sampedro2Juan Marín-Lahoz3Juan Marín-Lahoz4Juan Marín-Lahoz5Saul Martínez-Horta6Saul Martínez-Horta7Saul Martínez-Horta8Javier Pagonabarraga9Javier Pagonabarraga10Javier Pagonabarraga11Jaime Kulisevsky12Jaime Kulisevsky13Jaime Kulisevsky14Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, SpainBiomedical Research Institute (IIB-Sant Pau), Barcelona, SpainCentro de Investigación Biomédica en Red Enfermedades Neurodegenerativas, Madrid, SpainMovement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, SpainBiomedical Research Institute (IIB-Sant Pau), Barcelona, SpainCentro de Investigación Biomédica en Red Enfermedades Neurodegenerativas, Madrid, SpainMovement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, SpainBiomedical Research Institute (IIB-Sant Pau), Barcelona, SpainCentro de Investigación Biomédica en Red Enfermedades Neurodegenerativas, Madrid, SpainMovement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, SpainBiomedical Research Institute (IIB-Sant Pau), Barcelona, SpainCentro de Investigación Biomédica en Red Enfermedades Neurodegenerativas, Madrid, SpainMovement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, SpainBiomedical Research Institute (IIB-Sant Pau), Barcelona, SpainCentro de Investigación Biomédica en Red Enfermedades Neurodegenerativas, Madrid, SpainThe MAPT H1 haplotype has been identified as a predictor of cognitive decline in Parkinson's disease (PD). However, its underlying pathological mechanisms have not been fully established. In this work, using a cohort of 120 de novo PD patients with preserved cognition from the Parkinson's Progression Markers Initiative (PPMI) database, we found that patients who were homozygous for MAPT H1 had less gray matter volume (GMV) and greater 1-year GMV loss than patients without this genetic profile. Importantly, these changes were associated with a longitudinal worsening of cognitive indicators. Our findings suggest that early GMV loss in MAPT H1H1 PD patients increases their risk to develop cognitive decline.https://www.frontiersin.org/article/10.3389/fneur.2018.00394/fullMAPTT1-MRIcognitive declineParkinson's diseasegray matter volume
spellingShingle Frederic Sampedro
Frederic Sampedro
Frederic Sampedro
Juan Marín-Lahoz
Juan Marín-Lahoz
Juan Marín-Lahoz
Saul Martínez-Horta
Saul Martínez-Horta
Saul Martínez-Horta
Javier Pagonabarraga
Javier Pagonabarraga
Javier Pagonabarraga
Jaime Kulisevsky
Jaime Kulisevsky
Jaime Kulisevsky
Early Gray Matter Volume Loss in MAPT H1H1 de Novo PD Patients: A Possible Association With Cognitive Decline
MAPT
T1-MRI
cognitive decline
Parkinson's disease
gray matter volume
title Early Gray Matter Volume Loss in MAPT H1H1 de Novo PD Patients: A Possible Association With Cognitive Decline
title_full Early Gray Matter Volume Loss in MAPT H1H1 de Novo PD Patients: A Possible Association With Cognitive Decline
title_fullStr Early Gray Matter Volume Loss in MAPT H1H1 de Novo PD Patients: A Possible Association With Cognitive Decline
title_full_unstemmed Early Gray Matter Volume Loss in MAPT H1H1 de Novo PD Patients: A Possible Association With Cognitive Decline
title_short Early Gray Matter Volume Loss in MAPT H1H1 de Novo PD Patients: A Possible Association With Cognitive Decline
title_sort early gray matter volume loss in mapt h1h1 de novo pd patients a possible association with cognitive decline
topic MAPT
T1-MRI
cognitive decline
Parkinson's disease
gray matter volume
url https://www.frontiersin.org/article/10.3389/fneur.2018.00394/full
work_keys_str_mv AT fredericsampedro earlygraymattervolumelossinmapth1h1denovopdpatientsapossibleassociationwithcognitivedecline
AT fredericsampedro earlygraymattervolumelossinmapth1h1denovopdpatientsapossibleassociationwithcognitivedecline
AT fredericsampedro earlygraymattervolumelossinmapth1h1denovopdpatientsapossibleassociationwithcognitivedecline
AT juanmarinlahoz earlygraymattervolumelossinmapth1h1denovopdpatientsapossibleassociationwithcognitivedecline
AT juanmarinlahoz earlygraymattervolumelossinmapth1h1denovopdpatientsapossibleassociationwithcognitivedecline
AT juanmarinlahoz earlygraymattervolumelossinmapth1h1denovopdpatientsapossibleassociationwithcognitivedecline
AT saulmartinezhorta earlygraymattervolumelossinmapth1h1denovopdpatientsapossibleassociationwithcognitivedecline
AT saulmartinezhorta earlygraymattervolumelossinmapth1h1denovopdpatientsapossibleassociationwithcognitivedecline
AT saulmartinezhorta earlygraymattervolumelossinmapth1h1denovopdpatientsapossibleassociationwithcognitivedecline
AT javierpagonabarraga earlygraymattervolumelossinmapth1h1denovopdpatientsapossibleassociationwithcognitivedecline
AT javierpagonabarraga earlygraymattervolumelossinmapth1h1denovopdpatientsapossibleassociationwithcognitivedecline
AT javierpagonabarraga earlygraymattervolumelossinmapth1h1denovopdpatientsapossibleassociationwithcognitivedecline
AT jaimekulisevsky earlygraymattervolumelossinmapth1h1denovopdpatientsapossibleassociationwithcognitivedecline
AT jaimekulisevsky earlygraymattervolumelossinmapth1h1denovopdpatientsapossibleassociationwithcognitivedecline
AT jaimekulisevsky earlygraymattervolumelossinmapth1h1denovopdpatientsapossibleassociationwithcognitivedecline